META
Meta Platforms, Inc.
META's fundamentals are mixed, but it looks cheap: trading at 21x earnings, below its usual 27x. Analysts expect earnings growth, though they disagree widely on how much.
PSO
Pearson plc
There isn't enough reported data to score PSO yet.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
PSO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate PSO's fundamentals.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | โ |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | โ |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
PSO PE Valuation
PSO has no meaningful PE right now: it lost money over the past year.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
PSO Forward outlook
There aren't enough analyst estimates for PSO to show an outlook.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
PSO Earnings Per Share
PSO and META do not have enough comparable growth data to identify a winner.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over PSO in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over PSO on profitability, with a higher operating margin.
PSO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.4B | +4.1% |
| Q4 2025 | $2.5B | +2.5% |
| Q2 2025 | $2.3B | -1.8% |
| Q4 2024 | $2.4B | +0.2% |
| Q2 2024 | $2.3B | -6.7% |
| Q4 2023 | $2.4B | -13% |
| Q2 2023 | $2.5B | +5.1% |
| Q4 2022 | $2.7B | +12% |
PSO's revenue has slid since its 2013 peak: $2.4B last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +1.7 points |
| Q4 2025 | 15% | 0 points |
| Q2 2025 | 14% | +1.7 points |
| Q4 2024 | 18% | +5.2 points |
| Q2 2024 | 12% | +4.9 points |
| Q4 2023 | 15% | +9.2 points |
| Q2 2023 | 12% | +6 points |
| Q4 2022 | 13% | -3.3 points |
PSO's operating margin was 14% last quarter, up 1.7 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was โ$1.2B, but it generated $28.6B over the past year.
PSO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $420.4M | +78% |
| Q4 2025 | $612.7M | +3.3% |
| Q2 2025 | $236.8M | +212% |
| Q4 2024 | $593.3M | -2.8% |
| Q2 2024 | $75.8M | +$129M |
| Q4 2023 | $610.6M | +28% |
| Q2 2023 | -$53.2M | +$18.6M |
| Q4 2022 | $476.2M | +17% |
PSO generated $1.9B in free cash flow over the past year, up 68% from the year before.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
PSO Net Leverage
PSO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
PSO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 60.8 | Neutral |
PSO's weekly RSI is 59 (neutral) and its Stochastic is 61 (neutral).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
PSO PE vs Communication Services Sector
| Metric | PSO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | โ |
PSO has no meaningful PE right now: it lost money over the past year.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
PSO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.2 | 0.2% above |
| 20 week MA | $16.7 | 3.1% above |
| 50 week MA | $15.0 | 15% above |
| 100 week MA | $15.1 | 14% above |
| 200 week MA | $13.6 | 27% above |
PSO has the edge over META on trend strength, trading above more of its moving averages.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to โ65% in 2022. It's down 6% so far in 2026.
PSO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.49 | $9.21 | +8.5% |
| 2021 | $9.21 | $8.19 | -11% |
| 2022 | $8.19 | $11.3 | +37% |
| 2023 | $11.3 | $12.3 | +9.2% |
| 2024 | $12.3 | $16.2 | +32% |
| 2025 | $16.2 | $14.2 | -12% |
| 2026 YTD | $14.2 | $17.2 | +21% |
PSO has the edge over META on returns for 2026, with the stronger performance.